Attention-deficit hyperactivity disorder (ADHD) and autism are both heritable, polygenic neurodevelopmental disorders with similar symptoms. Both disorders have onset in childhood and occur more frequently in boys than in girls. Genetic studies have so far focused mostly on candidate genes involved in dopaminergic system, however more non-replications than positive associations were reported. The present study tested the possible association of the variants in dopamine system genes with these disorders in Croatian population. Polymorphisms of the dopamine receptor D4 (DRD4 variable number of tandem repeats), catechol-o-methyltransferase (COMT Val108/158Met), dopamine-beta-hydroxylase (DBH -1021C/T) and monoamine oxidase type B (MAO-B intron 13 polymorphism) were analyzed in unrelated male Caucasian subjects: 128 control subjects, 102 children with ADHD and 80 subjects with autism, diagnosed according to DSM-IV criteria. This study detected significantly reduced frequency of DRD4 L allele in autistic compared to other groups and increased frequency of the COMT Met/Met genotype in autistic and ADHD groups compared to control group. The frequency of the genotypes of DBH -1021C/T and MAO-B intron 13 polymorphisms was similar between subjects with ADHD or autism and healthy subjects. These results suggest that DRD4 L allele and the COMT Met/Met genotype might be associated with ADHD and autism
Introduction: This study aimed to analyze differences in sharing of prescription analgesics between rural and urban populations. Methods: We surveyed 1000 participants in outpatient family medicine settings in Croatia. We used a 35-item questionnaire to analyze patients’ characteristics, pain intensity, prescription analgesic sharing behavior, and perception of risks regarding sharing prescription medications. Results: Prescription analgesic sharing was significantly more frequent in the rural (64%) than in the urban population 55% (p = 0.01). Participants from rural areas more commonly asked for verbal or written information than those from urban areas when taking others’ prescription analgesics (p < 0.001) or giving such analgesics (p < 0.001). Participants from rural areas more commonly informed their physician about such behavior compared to those from urban areas (p < 0.01), and they were significantly more often asked about such behavior by their physician (p < 0.01). Perceptions about risks associated with sharing prescription medication were similar between rural and urban populations. Conclusions: There are systematic differences in the frequency of prescription analgesics and associated behaviors between patients in family medicine who live in rural and urban areas. Patients from rural areas were more prone to share prescription analgesics. Future studies should examine reasons for differences in sharing prescription analgesics between rural and urban areas.
Background: Health information and patient education on lifestyle changes may have a positive effect on the prevention of many chronic conditions, especially cardiovascular diseases (CVDs). We performed a parallel, three-arm randomized controlled trial (RCT) of 6-month educational intervention in a form of letters containing a reminder of the participant’s CVD risk with or without Cochrane blogshots to reduce CVD risk among women aged 45–65 with one or more known CVD risk factors. Methods: The control group received a letter about their CVD risk at the beginning of the trial. The intervention groups received the initial letter about their CVD risk and remainder letters about their CVD risk every 2 months, with or without Cochrane blogshots: (1) effect of calcium in the prevention of high blood pressure, (2) effect of reducing saturated fat acids in eating habits, and (3) effects of green and black tea in CVD prevention. The primary outcome was CVD risk reduction calculated as the difference between the baseline and 6-month score for a 10-year risk of fatal CVD according to the ACC/AHA guidelines. Results: After both interventions, CVD risk reduction was significantly higher compared to the control group (P < 0.001, Kruskal-Wallis H test). The number of participants who decreased their CV risk was 29% (20/70) in the control group, 69% (48/70) in the group receiving the reminder letters, and 70% (49/70) in the group receiving the reminder letters and blogshots. The number needed to treat to achieve risk reduction was 2.41 (95% CI = 1.77 to 3.78) for letters with a CVD risk reminder and 2.50 (1.81 to 4.03) for letters with a reminder and a blogshot. The group receiving reminder letters with Cochrane blogshots had a significant change in the category of CVD risk, mainly from high to moderate and from moderate to low CVD risk category. Conclusions: A simple and inexpensive intervention method in a form of letters reminding women about their CVD risk with or without providing additional health information in the form of Cochrane blogshots about interventions for important CVD risk factors may be effective in CVD management and could be considered by primary care providers. Trial registration: ClinicalTrials.gov, NCT04601558. Retrospectively registered on October 19, 2020
30 September 2024 in Acta Dermatovenerologica Alpina Pannonica et Adriatica
Introduction: Skin cancer, a significant global health issue, requires prompt detection and management, particularly among the elderly. Primary care physicians play a critical role in early diagnosis because they are often the first to evaluate patients with skin lesions. Accurate diagnosis by family physicians is essential for effective treatment and improved patient outcomes. Methods: Over a 12-year period, this study analyzed 125 samples from 89 patients that presented with visible skin changes or suspicious lesions identified during routine examinations. Initial working diagnoses made by family physicians were compared to final pathohistological diagnoses (PHD). Results: The study found a significant difference between working diagnoses and final PHDs for malignant versus benign cases, with an accuracy of 83.3% and statistical significance (p p = 0.04). A difference of 12.9% was observed, indicating areas for improvement. The diagnostic effectiveness for premalignant versus benign cases is high (accuracy of 88.2%), but without statistical significance (p p = 0.50), and it suggests that these differences are not clinically relevant. Conclusions: Primary care physicians demonstrate high accuracy in identifying malignant skin conditions, which is crucial for effective skin cancer management. However, improving diagnostic accuracy, particularly to reduce the misclassification of benign conditions as malignant, remains necessary. Continued training and development are essential to further enhance diagnostic precision for all skin conditions.
Introduction: Digoxin and its derivatives remain valuable adjunctive therapies for rate control in atrial fibrillation, yet their narrow therapeutic index poses a significant risk for neurotoxicity, particularly in the geriatric population. Case presentation: We report the case of a 79-year-old female with heart failure and chronic kidney disease who developed vivid, complex visual hallucinations 2 weeks after initiating methyldigoxin therapy. The patient’s medical history and subsequent magnetic resonance imaging revealed advanced subcortical vascular encephalopathy, characterized by confluent perivascular gliosis (Fazekas scale 3). This structural background initially raised suspicion of a transient ischemic attack or progressing vascular dementia. However, the patient maintained a high cognitive baseline (MMSE 28/30), and the hallucinations – which included perceiving her deceased husband and grandson – resolved completely within 4 days of methyldigoxin discontinuation. This rapid recovery, combined with the absence of new focal neurological deficits, suggests digitalis induced neurotoxicity rather than a primary cerebrovascular event. Conclusion: This case underscores the “clinical-radiological discrepancy” often encountered in elderly patients, where advanced neuroimaging findings may act as a confounding factor. It highlights the necessity of maintaining a high index of suspicion for drug-induced causes of acute neurological symptoms in patients with a “vulnerable brain” due to severe leukoaraiosis. Careful monitoring of digitalis compounds in patients with impaired renal function is mandatory to prevent misdiagnosis and unnecessary interventions.
Intra‐class differences may exist between ARBs regarding tissue‐specific outcomes. In this case, valsartan was probably associated with erectile dysfunction (Naranjo score 7). Switching to olmesartan was followed by resolutions of symptoms. An intra‐class switch may be considered in selected patients with suspected drug‐associated erectile dysfunction after evaluating other vascular, metabolic, or lifestyle contributions. Clinicians should remain cautious, as concurrent treatment modifications can confound definitive causal attributions.